Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : °øÁö»çÇ×
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [±â»ç]ÀǾàǰÁ¤Ã¥ ¿¬±¸¼Ò, »ó¹Ý±â ÀÚü°¨»ç ¼ö°¨
³»   ¿ë

ÀǾàǰÁ¤Ã¥ ¿¬±¸¼Ò, »ó¹Ý±â ÀÚü°¨»ç ¼ö°¨
¿ÜºÎ¿¬±¸¿ë¿ª ¼º°ú¡¤ÀÎ·Â Ãæ¿ø µî ¼³¸í¡¤¡¤¡¤º¹ÁöºÎ °¨»ç ÀÌÇà»çÇ× Á¡°Ë µî

 

 
(Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò(ÀÌ»çÀå Á¶ÂùÈÖ)´Â Áö³­ 9ÀÏ ¿¬±¸¼Ò ȸÀǽǿ¡¼­ 2017³âµµ »ó¹Ý±â ÀÚü°¨»ç¸¦ ¼ö°¨Çß´Ù.

À̳¯ °¨»ç¿¡¼­ ±è´ë¿ø ¼ÒÀåÀº ¿¬±¸¼ÒÀÇ »ó¹Ý±â ¿ÜºÎ¿¬±¸¿ë¿ª °è¾à ¼º°ú¿Í ½Å±Ô ¿¬±¸ÀÎ·Â Ãæ¿ø µî¿¡ ´ëÇÑ »çÇ×À» ¼³¸íÇϰí, °¨»ç¸¦ ¼º½ÇÇÏ°Ô ¹Þ°Ú´Ù´Â ¸»·Î Àλ縻À» ´ë½ÅÇß´Ù.

±èÅ¿ø, Á¤¿¬Åà °¨»ç´Â À̳¯ »ó¹Ý±â ȸ°è»çÇ×À» ºñ·ÔÇØ ¿¬±¸»ç¾÷º° ÁøÇà»çÇ× µîÀ» È®ÀÎ, ÁúÀÇÇÏ¸ç »ó¼¼ÇÏ°Ô °¨»ç¸¦ ÁøÇàÇß´Ù.

ƯÈ÷ º¸°Çº¹ÁöºÎ Á¾ÇÕ°¨»ç ¼ö°¨(2/9~2/10)¿¡ µû¸¥ Á¶Ä¡»çÇ×ÀÇ ÀÌÇà »óŸ¦ ¸é¹ÐÈ÷ Á¡°ËÇß´Ù.

°¨»ç´ÜÀº Àü³â µ¿±â ´ëºñ 70%¡¡Ãʰú ´Þ¼ºÇÑ »ó¹Ý±â ¼º°ú ¹× ¿ë¿ª¿¬±¸ ¼öÇà¿¡ µû¸¥ ¿¬±¸¿øµéÀÇ ³ë·ÂÀ» °Ý·ÁÇß´Ù.

ÀÌ¾î ¡°½Å±Ô ¿¬±¸ÀηÂÀ» È¿À²ÀûÀ¸·Î Ȱ¿ëÇØ Àü³âµµ °è¼Ó »ç¾÷À» ¿Ï·áÇÏ°í ³»³âµµ ¿¬±¸¿ë¿ªÀÇ ¼öÁÖó¸¦ ´Ùº¯È­ÇØ Àû±ØÀûÀ¸·Î ¼öÁÖÇϵµ·Ï ³ë·ÂÇØ ´Þ¶ó¡±°í ´çºÎÇß´Ù.

±è´ë¿ø ¼ÒÀåÀº ¡°¿¬±¸¼Ò°¡ º¸´Ù ³»½Ç ÀÖ°Ô ÇÑÃþ µµ¾àÇÒ ¼ö ÀÖµµ·Ï ÃÖ¼±À» ´ÙÇϰڴ١±°í ¸»Çß´Ù.
 
Ç㼺±Ô skheo85@hanmail.net

 

 

 

Ãâó : http://www.kpanews.co.kr/article/show.asp?idx=186268&table=article&category=F

 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
123 [±â»ç]ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò °á»ê ÀÚü°¨»ç ¼ö°¨ °ü¸®ÀÚ 2018-02-19 1330
122 [±â»ç]¾à±¹, '°í°´»ó´ã ±â¹ý ¡¤ ÀÏ¹Ý¾à ±³À°' °æ¿µ°³¼± À§ÇØ °¡Àå ÇÊ¿ä °ü¸®ÀÚ 2018-02-19 1564
121 [±â»ç]ÀÏ»ó¿¡ ÁöÄ£ ¾à»çµé, ³ª¸¸ÀÇ Ãë¹Ì¿¡ ºüÁ®º¸¶ó °ü¸®ÀÚ 2018-02-05 1333
120 [±â»ç]°è¼ÓµÇ´Â °ø°ø½É¾ß¾à±¹ °³¼³¡¦À̹ø¿£ ¾È¾ç¡¤È­¼º °ü¸®ÀÚ 2018-02-02 1773
119 [±â»ç]Á¶Á¦ °³³ä, Àü¹®¼º¿¡ ¸Â°Ô ¹Ù²ã¾ß °ü¸®ÀÚ 2018-01-31 1491
118 [±â»ç]ȸ¿øÀÌ Áñ±â´Â ¸ð¹ÙÀÏ È¨ÆäÀÌÁö ±¸Ãà °ü¸®ÀÚ 2018-01-30 1427
117 ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ±è´ë¿ø ¼ÒÀå ½Å³â»ç ±è´ë¿ø 2018-01-05 1591
116 [±â»ç][Ä®·³] ÀǾàǰ ¾ÈÀü»ç¿ë±³À°ÀÇ ¼º°ú¿Í °úÁ¦ °ü¸®ÀÚ 2017-12-27 1579
115 [±â»ç]¾î¸°ÀÌ ´Ùºóµµ Áúȯ¡¤ÀǾàǰ Á¤º¸, Á÷Á¢ È®ÀÎÇØº¸¼¼¿ä °ü¸®ÀÚ 2017-11-27 1713
114 [±â»ç][±â°í] »ìÃæÁ¦°è¶õ, À¯Çع°Áú »ý¸®´ëÀÇ ¼ÒºñÀÚ ½Ã°¢ °ü¸®ÀÚ 2017-09-15 1890
113 [±â»ç]"°æ±â ½É¾ß°ø°ø¾à±¹ ÀûÇÕ"...°³Àξ౹¡¤24½Ã°£ ¼­ºñ½ºÇü Á¢±Ù °ü¸®ÀÚ 2017-09-07 2114
112 [±â»ç]½É¾ß¾à±¹ µµÀÔ...¾à°è "Ãë¾à½Ã°£´ë º¸¿Ï" vs Á¤ºÎ "ÀçÁ¤ ºÎ´ã" °ü¸®ÀÚ 2017-09-07 2068
111 [±â»ç]¼­¸é¹æ½Ä Çã¿ë, ¾à»ç Àνĺ¯È­¿¡ ±àÁ¤Àû ¿µÇâ °ü¸®ÀÚ 2017-08-29 2255
110 [±â»ç]ÀǾàǰÁ¤Ã¥ ¿¬±¸¼Ò, »ó¹Ý±â ÀÚü°¨»ç ¼ö°¨ °ü¸®ÀÚ 2017-08-16 1518
109 [±â»ç]¾à»ç Á÷´É ¹Ì·¡ Á¸¸³ÀÇ ÇØ¹ýÀº 'ȯÀÚ¿ÍÀÇ ¼ÒÅë' °ü¸®ÀÚ 2017-07-12 1884

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  [10]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»